Quick Takes

Thank You for Giving Tuesday

The Pulmonary Hypertension Association (PHA) received $101,410 on Giving Tuesday, a global day of giving. Thanks to the generosity of the pulmonary hypertension (PH) community, donations were up 45% from Giving Tuesday 2019. The donations marked the largest amount PHA has raised on a Giving Tuesday. The record amount was possible thanks to 321 donors and a $25,000 match. Thanks to everyone who supported PHA’s Giving Tuesday campaign. You help PHA extend and improve the lives of those affected by PH.

Ensure Timely Prescription Refills

If your insurance coverage is changing in January 2021, follow these steps to make sure your first medication refill of the new year arrives on time:

Update your pulmonary hypertension (PH) care team. Many health insurance plans include prior authorization or step therapy requirements for PH medication. Your health care team might need to complete new paperwork or file an appeal to give you seamless access to your therapy. Alert your health care team to your insurance change to allow them to tackle obstacles now and reduce the chances of delays in the new year.

Ask your health care team to prescribe a 60- or 90-day supply for your last refill of this year. Multi-month refills further reduce the risk of delays for those who are eligible.

Update your specialty pharmacy. Your new insurance plan might work with different specialty pharmacies to deliver PH therapy than your current plan. It’s important to notify your specialty pharmacies that you’re changing health insurance plans.

Review your financial assistance options. Changes in your health insurance coverage sometimes can change which copay assistance you’re eligible for. Manufacturer assistance programs, nonprofit grants and government-funded support programs have different eligibility criteria. Contact PHA’s Treatment Access Program at PHAssociation.org/HELP for information. Call 301-565-3004 x749 or email us at Insurance@ PHAssociation.org.

PHA thanks Janssen Pharmaceuticals Inc. for its support of PHA’s Treatment Access Program.